| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.
|
J Clin Oncol
|
2007
|
4.93
|
|
2
|
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
|
J Clin Oncol
|
2012
|
1.56
|
|
3
|
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
|
J Clin Oncol
|
2009
|
1.24
|
|
4
|
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
|
Eur J Haematol
|
2007
|
1.13
|
|
5
|
High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20,653 stem cell donors.
|
Hum Immunol
|
2011
|
1.11
|
|
6
|
Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study.
|
Br J Haematol
|
2008
|
1.00
|
|
7
|
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
|
Blood
|
2006
|
0.97
|
|
8
|
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
|
Blood
|
2007
|
0.91
|
|
9
|
ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
|
Pol J Pathol
|
2005
|
0.89
|
|
10
|
Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation.
|
Med Sci Monit
|
2011
|
0.87
|
|
11
|
Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
|
Eur J Haematol
|
2003
|
0.85
|
|
12
|
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis.
|
Leuk Res
|
2003
|
0.85
|
|
13
|
The effect of beta-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1.
|
Biochim Biophys Acta
|
2005
|
0.85
|
|
14
|
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
|
Med Sci Monit
|
2005
|
0.83
|
|
15
|
Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction.
|
Kardiol Pol
|
2006
|
0.82
|
|
16
|
Central nervous system prophylaxis with intrathecal liposomal cytarabine in diffuse large B-cell lymphomas.
|
Pol Arch Med Wewn
|
2013
|
0.81
|
|
17
|
Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
|
Ann Hematol
|
2007
|
0.81
|
|
18
|
The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.
|
Int J Hematol
|
2007
|
0.81
|
|
19
|
Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia.
|
Leuk Lymphoma
|
2009
|
0.81
|
|
20
|
[Angiogenesis in different clinical phases of chronic myeloid leukemia].
|
Przegl Lek
|
2009
|
0.80
|
|
21
|
Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study.
|
Int J Cardiol
|
2013
|
0.80
|
|
22
|
[Herpesviruses mixed infections in allogeneic steam cell recipients (allo-HSCT)].
|
Przegl Epidemiol
|
2008
|
0.79
|
|
23
|
[Implementation of direct sequencing as a method of ABL gene mutations analysis in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor].
|
Przegl Lek
|
2010
|
0.78
|
|
24
|
A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease.
|
JIMD Rep
|
2011
|
0.78
|
|
25
|
[Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
|
Przegl Lek
|
2013
|
0.78
|
|
26
|
[Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases].
|
Pol Arch Med Wewn
|
2003
|
0.78
|
|
27
|
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
|
Med Oncol
|
2015
|
0.77
|
|
28
|
The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study.
|
Am J Hematol
|
2011
|
0.77
|
|
29
|
Bleeding tendency and prolonged wound healing in a patient with A alphaArg16His dysfibrinogenemia: fibrinogen Krakow IV.
|
Thromb Res
|
2011
|
0.77
|
|
30
|
[Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
|
Przegl Lek
|
2010
|
0.76
|
|
31
|
Morphometric classification of hairy cell leukemia in bone marrow trephine biopsy.
|
Anal Quant Cytol Histol
|
2003
|
0.75
|
|
32
|
[H-oCT1 gene expression as a predictor of major and complete molecular response to imatinib of chronic myeloid leukemia. Single center experience].
|
Przegl Lek
|
2011
|
0.75
|
|
33
|
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report.
|
J Med Case Rep
|
2014
|
0.75
|
|
34
|
[Concomitant myeloid sarcoma and plasma cell myeloma--case report of a hitherto undescribed association of two neoplasms].
|
Pol Merkur Lekarski
|
2007
|
0.75
|
|
35
|
The use of the Congo red-related dye DBACR to recognize the heavy chain-derived abnormality of myeloma immunoglobulins.
|
Arch Immunol Ther Exp (Warsz)
|
2006
|
0.75
|
|
36
|
Radioimmunotherapy for lymphoma - analysis of clinical trials and treatment algorithms.
|
Nucl Med Rev Cent East Eur
|
2007
|
0.75
|
|
37
|
Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
|
Thromb Haemost
|
2009
|
0.75
|
|
38
|
New forms of radionuclide therapy with (90)Y in oncology.
|
Nucl Med Rev Cent East Eur
|
2008
|
0.75
|
|
39
|
[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].
|
Przegl Lek
|
2010
|
0.75
|
|
40
|
[Cutaneous involvement in multiple myeloma--case report and literature review].
|
Przegl Lek
|
2015
|
0.75
|
|
41
|
[Activity of the Cracow Physicians Society concerning documentation and systematic strengthening of the memory of criminal genocides during World War II].
|
Przegl Lek
|
2013
|
0.75
|
|
42
|
[Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience].
|
Przegl Lek
|
2011
|
0.75
|
|
43
|
[Hematological toxicity of radioimmunotherpy with 90Y Ibritumomab].
|
Przegl Lek
|
2012
|
0.75
|
|
44
|
[Waldenström's macroglobulinemia--the experts opinion about new therapeutic possibilities and response criteria].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
45
|
Neopterin and other inflammatory markers in the early period following allogeneic bone marrow transplantation: series of 3 cases.
|
Pol Arch Med Wewn
|
2009
|
0.75
|
|
46
|
High prevalence of non-Hodgkin's lymphomas in Polish population--1106 new cases diagnosed according to WHO classification in only one district.
|
Pol J Pathol
|
2006
|
0.75
|
|
47
|
Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
|
Pol J Pathol
|
2002
|
0.75
|
|
48
|
[Severe depression with psychotic symptoms, diagnosed in the final stage of treatment of acute bi-phenotype leukemia].
|
Psychiatr Pol
|
2002
|
0.75
|
|
49
|
The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.
|
Eur J Haematol
|
2014
|
0.75
|
|
50
|
[Beta-carotene regulates the expression of proapoptotic BAX and CAPN2 in HL-60, U-937 and TF-1 - human acute myeloid leukemia cell lines; microarray, RQ-PCR and Western Blot analysis].
|
Przegl Lek
|
2011
|
0.75
|
|
51
|
Bone marrow suppression with plasma cell leukemia‑like reaction complicated by macrophage activation syndrome after metamizole overuse.
|
Pol Arch Med Wewn
|
2013
|
0.75
|
|
52
|
[Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].
|
Przegl Lek
|
2014
|
0.75
|
|
53
|
[Traumatic epidural hematoma in a patient with von Willebrand's disease].
|
Przegl Lek
|
2003
|
0.75
|
|
54
|
Digestive complaints in patients with hematologic malignancies undergoing bone marrow transplantation.
|
Onkologie
|
2011
|
0.75
|
|
55
|
Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results.
|
Med Oncol
|
2011
|
0.75
|
|
56
|
[Hepatocyte growth factor: from diagnosis to clinical application].
|
Przegl Lek
|
2003
|
0.75
|
|
57
|
[ABL domain kinase point mutations as a cause of resistance to therapy of patients with chronic myeloid leukemia with tyrosine kinase inhibitors. Single center experience].
|
Przegl Lek
|
2011
|
0.75
|
|
58
|
Importance of parenteral nutrition in patients undergoing allogeneic hematopoietic stem cell transplantation.
|
Onkologie
|
2011
|
0.75
|
|
59
|
Idiopathic myelofibrosis with fatty bone marrow: an issue of sampling? A propos an unusual case.
|
Haematologica
|
2003
|
0.75
|
|
60
|
Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study.
|
Leuk Lymphoma
|
2009
|
0.75
|
|
61
|
Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
|
Blood Coagul Fibrinolysis
|
2009
|
0.75
|
|
62
|
[Granulocytic sarcoma with late transformation into acute myeloblastic leukemia--case report].
|
Przegl Lek
|
2006
|
0.75
|
|
63
|
[Primary adrenal lymphoma in incidentally discovered adrenal tumour].
|
Przegl Lek
|
2006
|
0.75
|
|
64
|
Radioimmunotherapy in follicular lymphomas, a retrospective analysis of the Polish Lymphoma Research Group's (PLRG) experience.
|
Nucl Med Rev Cent East Eur
|
2007
|
0.75
|
|
65
|
Is it possible to identify siblings by studying bone marrow under a microscope? Two unusual cases of Gaucher disease.
|
Pol J Pathol
|
2002
|
0.75
|
|
66
|
Complex cytogenetics in a case of probably work related MDS/AML.
|
Leuk Res
|
2004
|
0.75
|
|
67
|
[Iron deficiency anaemia in population of Polish patients--results of epidemiological screening study].
|
Pol Merkur Lekarski
|
2005
|
0.75
|
|
68
|
[The importance of imaging techniques in the modern treatment of multiple myeloma].
|
Przegl Lek
|
2014
|
0.75
|
|
69
|
[Depressive disorders in leukemia].
|
Psychiatr Pol
|
2003
|
0.75
|
|
70
|
Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2013
|
0.75
|
|
71
|
[Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
|
Przegl Lek
|
2011
|
0.75
|
|
72
|
[Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].
|
Przegl Lek
|
2012
|
0.75
|
|
73
|
[Infections with Van B phenotype Enterococcus faecium and E. faecalis in patients with immune deficiency during the course of hematologic neoplasms].
|
Med Dosw Mikrobiol
|
2003
|
0.75
|
|
74
|
[Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
|
Przegl Lek
|
2003
|
0.75
|
|
75
|
[Management of multiple myeloma-related bone disease].
|
Przegl Lek
|
2013
|
0.75
|
|
76
|
[Significant changes in diagnostic and therapeutic procedures in smoldering multiple myeloma].
|
Przegl Lek
|
2015
|
0.75
|
|
77
|
[IgA multiple myeloma with adverse prognostic factors--a case report].
|
Przegl Lek
|
2009
|
0.75
|
|
78
|
[Non Hodgkin lymphoma during pregnancy].
|
Ginekol Pol
|
2005
|
0.75
|
|
79
|
Efficacy and safety of stem cell mobilization with cyclophosphamide plus etoposide versus cyclophosphamide alone.
|
Przegl Lek
|
2015
|
0.75
|
|
80
|
[Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
|
Przegl Lek
|
2003
|
0.75
|
|
81
|
[High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience].
|
Przegl Lek
|
2011
|
0.75
|